BMC Cancer Oncology

METTL16-dependent miR-146b-5p m6A modification remodeling sensitize NSCLC to osimertinib via activating PI3K/AKT signaling

Hongyang Sang, Jinlong Liu, Xifang Chen, Yingou Zeng
Springer Nature · 2025-04-08 · DOI 10.1186/s12885-025-14041-y

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →